Oligodendrocyte pathophysiology: a new view of schizophrenia
- PMID: 17291369
- DOI: 10.1017/S146114570600722X
Oligodendrocyte pathophysiology: a new view of schizophrenia
Abstract
A recent focus of schizophrenia research is disruption of white-matter integrity as a key facet of this complex disorder. This was spurred, partly, by new imaging modalities, magnetic transfer imaging and diffusion tensor imaging, which showed differences in white-matter integrity and tract coherence in persons with schizophrenia compared to controls. Oligodendrocytes, in particular, have been the subject of increased study after gene microarray analyses revealed that six myelin-related genes specific to oligodendrocytes have decreased expression levels in schizophrenia. Oligodendrocytes have also been shown to be decreased in number in the superior frontal gyrus of subjects with schizophrenia. The MAG knockout mouse, missing a myelin-related gene linked to schizophrenia, may prove to be a useful animal model for the dysmyelination observed in the human disease. Studies currently ongoing on this model have found changes in dendritic branching patterns of pyramidal cells in layer III of the prefrontal cortex. Further characterization of the pathology in these mice is underway.
Similar articles
-
Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia.Int J Neuropsychopharmacol. 2007 Aug;10(4):565-73. doi: 10.1017/S1461145706007310. Epub 2007 Feb 12. Int J Neuropsychopharmacol. 2007. PMID: 17291370
-
Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.Neuropsychopharmacology. 2008 Nov;33(12):2993-3009. doi: 10.1038/npp.2008.19. Epub 2008 Mar 5. Neuropsychopharmacology. 2008. PMID: 18322470
-
Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia.Int J Neuropsychopharmacol. 2007 Aug;10(4):499-502. doi: 10.1017/S1461145706007449. Int J Neuropsychopharmacol. 2007. PMID: 17583597
-
White matter and cognitive function in schizophrenia.Int J Neuropsychopharmacol. 2007 Aug;10(4):513-36. doi: 10.1017/S1461145707007638. Epub 2007 Feb 21. Int J Neuropsychopharmacol. 2007. PMID: 17313699 Review.
-
Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia.Int Rev Neurobiol. 2004;59:381-424. doi: 10.1016/S0074-7742(04)59015-3. Int Rev Neurobiol. 2004. PMID: 15006496 Review. No abstract available.
Cited by
-
White matter abnormalities in 22q11.2 deletion syndrome: preliminary associations with the Nogo-66 receptor gene and symptoms of psychosis.Schizophr Res. 2014 Jan;152(1):117-23. doi: 10.1016/j.schres.2013.11.015. Epub 2013 Dec 8. Schizophr Res. 2014. PMID: 24321711 Free PMC article.
-
Myelin-associated glycoprotein gene and brain morphometry in schizophrenia.Front Psychiatry. 2012 May 3;3:40. doi: 10.3389/fpsyt.2012.00040. eCollection 2012. Front Psychiatry. 2012. PMID: 22563322 Free PMC article.
-
Essential function, sophisticated regulation and pathological impact of the selective RNA-binding protein QKI in CNS myelin development.Future Neurol. 2008 Nov;3(6):655-668. doi: 10.2217/14796708.3.6.655. Future Neurol. 2008. PMID: 19727426 Free PMC article.
-
Convergence and divergence in the etiology of myelin impairment in psychiatric disorders and drug addiction.Neurochem Res. 2008 Oct;33(10):1940-9. doi: 10.1007/s11064-008-9693-x. Epub 2008 Apr 11. Neurochem Res. 2008. PMID: 18404371 Review.
-
Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease.Neuromolecular Med. 2012 Dec;14(4):270-80. doi: 10.1007/s12017-012-8185-y. Epub 2012 Jun 19. Neuromolecular Med. 2012. PMID: 22711522
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
